Pulmonary tuberculosis: Hematology, serum biochemistry and the relation with the disease duration

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 14, Issue 1, 2008, Pages 71-81

  Oliva, V M ^a   Cezario G A G ^a   Cocato, R A ^a   Marcondes Machado, Jussara ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Erythrocyte sedimentation rate; Hematolological and biochemical parameters; Mycobacterium tuberculosis; Pulmonary tuberculosis; Smoking

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 41749123438     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992008000100006     Document Type: Article

References (30)

1. AMIN Z. Clinical tuberculosis problems and management. Acta. Med. Indones., 2006, 38, 109-16.
2. ANDUS T., BAUER J., GEROK E. Effects of cytokines on the liver. Hepatology, 1991, 13, 364-75.
3. ARCAVI L., BENOWITZ NL. Cigarette smoking and infection. Arch. Intern. Med., 2004, 164, 2206-16.
4. BALLOU SP., LOZANSKI FB., HODDER S., RZEWNICKI DL., MION LC., SIPE JD., FORD AB., KUSHNER I. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing., 1996, 25, 224-38.
5. BASTA PC., COIMBRA JR CEA., ESCOBAR AL., SANTOS RV. Aspectos epidemiológicos da tuberculose na população indígena Suruí, Amazônia, Brasil. Rev. Soc. Bras. Med. Trop., 2004, 37, 338-42.
6. BEVILACQUA MP., POBER JS., MAJEAU GR., COTRAN RS., GIMBRONE JR MA. Interleukine 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med., 1984, 160, 618-23.
7. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de Controle de Tuberculose: avanços e desafios. Brasília, 2005.
8. BROWN D., MILES B., ZWILLING B. Growth of Mycobacterium tuberculosis in BCG-resistant and susceptible mice: establishment of latency and reactivation. Infect. Immun., 1995, 63, 2243-7.
9. CHAIMOWICZ F. Age transition of tuberculosis incidence and mortality in Brazil. Rev. Saúde Pub., 2001, 35, 81-7.
10. COHEN S., TYRRELL DA., RUSSELL MA., JARVIS MJ., SMITH AP. Smoking, alcohol consumption, and susceptibility to the common cold. Am. J. Public Health, 1993, 83, 1277-83.
11. DANNENBERG JR A. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today, 1991, 12, 228-33.
12. DLUGOVITZKY D., TORRES-MORALES A., RATENI L., FARRONI MA., LARGACHA C., MOLTENI O., BOTTASSO O. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol., 1997, 18, 203-7.
13. FERREIRA AAA., QUEIROZ KCS., TORRES KP., FERREIRA MAF., ACCIOLY H., ALVES MSCF. Os fatores associados à tuberculose pulmonar e a baciloscopia: uma contribuição ao diagnóstico nos serviços de saúde pública. Rev. Bras. Pneumol., 2005, 8,142-49.
14. FLYNN J., GOLDSTEIN M., CHAN J., TRIEBOLD K., PFEFFER K., LOWENSTEIN C., SCHRELBER R., MAK TW., BLOOM BR. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 1995, 2, 561-72.
15. KARTALOGLU Z., CERRAHOGLU K., OKUTAN O., OZTURK A., AYDILEK R. Parameters of blood coagulation in patients with pulmonary tuberculosis. J. Intern. Med., 2001, 2, 2.
16. LIMA FILHO MT. Patogenia da tuberculose. J. Pneumol., 1993, 19, 11-18.
17. OPPENHEIM JJ., GERY I. Interleukin-1 is more than an interleukin. Immunol. Today, 1982, 3, 113-19.
18. RAVIGLIONE MC., SNIDER JR DE., KOCHI A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. J. Am. Med. Assoc., 1995, 273, 220-26.
19. RICH EA., TORRES M., SADA E., FINEGAN CK., HAMILTON BD., TOOSSI Z. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung Dis., 1997, 78, 247-55.
20. RUFFINO MC., NETO AR. Associação entre alcoolismo e tuberculose pulmonar. Rev. Saúde Púb., 1979, 13, 183-94.
21. SANTO AH., PINHEIRO CE., JORDANI MS. Causas múltiplas de morte relacionadas à tuberculose no Estado de São Paulo, 1998. Rev. Saúde Púb., 2003, 37, 714-21.
22. SANTOS VM., CUNHA SF., CUNHA DF. Velocidade de sedimentação das hemácias: utilidades e limitações. Rev. Assoc. Med. Brasil, 2000, 46, 232-6.
23. SHIRAN SD., BOVIN NV. Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha-1-acid glycoprotein. Glycoconj. J., 1997, 14, 631-38.
24. SINGH KJ., AHLUWALIA G., SHARMA SK., SAXENA R., CHAUDHARY VP., ANANT M. Significance of haematological manifestation in patients with tuberculosis. J. Assoc. Physicians India, 2001, 49, 790-94.
25. SOX HC., LIANG MH. The erythrocyte sedimentation rate. Ann. Int. Med., 1986, 104, 515-23.
26. SUDRE P., TEN DAM G., KOCHI A. Tuberculosis: a global overview of the situation today. Bull. W. H. O., 1992, 70, 149-59.
27. WATKINS RE., PLANT AJ. Does smoking explain sex differences in the global tuberculosis epidemic? Epidemiol. Infect., 2006, 134, 333-39.
28. WINZLER RJ. The plasma proteins. Nova York: Academic Press, 1960.
29. WOLFE F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J. Rheumatol., 1997, 24, 1477-85.
30. YAMADA H., MIZUMO S., HORAI R., IWAKURA Y., SUGAWARA I. Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab. Invest., 2000, 80, 759-67.